Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Weekly ABI-007 Plus TS-1 in Metastatic Breast Cancer
jRCT2080221553Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2011
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nab-paclitaxel and tegafur in breast cancer, sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
nab-paclitaxeltegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080221553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221553.